Loading
A tissue test that sorts a bladder cancer into molecular types, which may help judge how it will respond to chemotherapy before surgery.
Veracyte states that "Based on the expression of 219 genes" the test "classifies bladder tumors by molecular subtype", that it is run on tissue from transurethral resection and "is intended for patients with clinical stage T1 to T4a bladder cancer", that it is a laboratory-developed test that "has not been cleared or approved by the FDA", and that it "is covered by Medicare for patients with clinical stage T1-T4a bladder cancer". The Medicare group policy for bladder classifiers (L38576) does not name it. The classifier was described in a study of muscle-invasive bladder cancer in which a single-sample genomic subtyping classifier predicted four consensus subtypes with 73 per cent accuracy and patients with basal tumours showed the most improvement in overall survival with neoadjuvant chemotherapy (Seiler 2017).
Whole-transcriptome expression from tumour tissue taken at transurethral resection is reduced to 219 genes that assign a consensus molecular subtype of bladder cancer.
| Country | Reimbursement | List price | Assistance |
|---|---|---|---|
| United States | Medicare covers it for clinical stage T1 to T4a bladder cancer (Veracyte's statement; the MolDX bladder classifier policy L38576 does not name the test) | not disclosed | - |
List prices are manufacturer or Medicare figures where publicly disclosed; net prices after rebates are usually lower. Reimbursement changes; check the payer.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"Decipher Bladder" OR ABSTRACT:"Decipher Bladder" OR TITLE:"Decipher Bladder Genomic Subtyping Classifier" OR ABSTRACT:"Decipher Bladder Genomic Subtyping Classifier") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Decipher Bladder, not a curated reading list.
Shares Gene-expression prognostic assays, RNA sequencing & expression profiling and the tags test, rna.
Shares Gene-expression prognostic assays, RNA sequencing & expression profiling and the tags test, rna.
Shares Gene-expression prognostic assays, RNA sequencing & expression profiling and the tags test, rna.
Shares Gene-expression prognostic assays, RNA sequencing & expression profiling and the tags test, rna.
Shares Gene-expression prognostic assays and the tags test, rna.
Shares Gene-expression prognostic assays and the tags test, rna.
Shares Gene-expression prognostic assays and the tags test, rna.
Shares RNA sequencing & expression profiling and the tags test, rna.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/